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ABSTRACT
The CNS (central nervous system) is unquestionably the
central organ that regulates directly or indirectly all
physiological systems in the mammalian body. Yet, when
considering the defence of the CNS from pathogens, the
CNS has often been considered passive and subservient to
the pro-inflammatory responses of the immune system. In
this view, neuroinflammatory disorders are examples of
when the tail (the immune system) wags the dog (the CNS)
to the detriment of an individual’s function and survival.
Key words: autoimmunity, irradiation chimaeric mouse,
MyD88, neurodegeneration, pathogen conserved molecular
pattern (PAMP), Toll-like receptor.
In a paper recently published in ASN NEURO, Kielian and
colleagues use a Staphylococcus aureus model of brain
abscess formation to provide data challenging this commonly
stated dogma. Their results reinforce the emerging view of
the critical and non-redundant control of pathogen defence
by the CNS itself. Specifically, Kielian and colleagues not only
reveal the ability of the CNS to both initiate anti-bacterial
MyD88-dependent pro-inflammatory responses by CNS-
resident cells, they also reveal the surprising ability of these
CNS-initiated responses to apparently compensate for
pathogen-associated susceptibilities intrinsic to peripheral
immune system responses. The identification of immune-
system-intrinsic compared with CNS-intrinsic regulation of
neuroinflammatory responses is not merely an academic
exercise. Rather the degree and type of neuroinflammation
that can be initiated by the CNS-intrinsic mechanisms will
refocus the sites targeted for effective therapeutic interven-
tion of both pathogen- and non-pathogen-associated CNS
neuroinflammatory disorders.
WHY DID WE START ASSUMING THAT THE TAIL
WAGGED THE DOG?
In part, this viewpoint is derived from a long series of
observations begun nearly 100 years ago (reviewed in Carson
et al., 2006). Foreign tissue grafts (allografts) survive for
greater periods of time when placed within the brain
parenchyma than when they are placed under the skin. The
prolonged survival of allografts within the brain correlates
with the absence in the CNS of the robust and prominent
lymphocytic immune response observed in non-CNS graft sites.
These and subsequent observations led to the concept of
immunologically privileged sites being defined as tissues with
very high thresholds for initiating T-cell responses: the CNS
being defined as the stereotypical example. The persistence of
viruses and bacteria within the brain, even when these
pathogens had been cleared from all other tissue compart-
ments in the body, appeared to confirm this ‘neutral-no battle
zone’ interpretation of immune privilege. The adaptive
advantage for allowing persistence of pathogens within the
CNS is argued to be an adaptive balance between limiting
disruption of CNS function by the pathogen compared with by
the pro-inflammatory responses of immune cells. For example,
S. aureus-induced formation of brain abscesses clearly
interferes with CNS function. However, sequestration of an
infection that cannot be cleared within a brain abscess does
prevent the pathogen from inducing further harm and
simultaneously facilitates the termination of neurotoxic pro-
inflammatory anti-S. aureus-directed immune responses.
Numerous studies are now elucidating the multiple
molecular mechanisms that actively maintain immune
privilege. Notably, CNS neurons and glia express numerous
immunomodulatory molecules such as TGFb (transforming
growth factor b), CD200, CD22, fractalkine, CD47 and TREM2
(triggering receptor expressed on myeloid cells 2), all of which
have demonstrated immunosuppressive actions on pro-
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inflammatory immune responses (Takahashi et al., 2007;
reviewed in Carson et al., 2006; Carson and Lo, 2007).
Microglia, the resident CNS-specific tissue macrophages are
substantially less effective in initiating T-cell responses and have
substantially lower bactericidal function than peripheral pro-
inflammatory macrophages and neutrophils. (reviewed in Carson
et al., 2006; Garg et al., 2009). Taken together, these and other
results suggest that the CNS can actively modulate immune
system function, but that CNS-intrinsic regulation is biased
toward limiting, not initiating, pro-inflammatory responses.
CHALLENGING THE ACCEPTED PARADIGM
To understand how Kielian and colleagues (Garg et al., 2009)
challenged whether the CNS has an obligate bias towards
anti-inflammatory responses, it is important to define how
the immune system and CNS detect and initiate cellular
responses toward common pathogens. Cells in both the CNS
(microglia, astrocytes) and the immune system (neutrophils,
macrophages and many others) express receptors such as the
TLRs (Toll-like receptors) that recognize PAMPs (pathogen-
associated molecular patterns). For example, TLR2 binds the
peptioglycan found on the surface of S. aureus. Many (but
not all) of the intracellular signalling and pro-inflammatory
responses triggered by TLRs are dependent on the presence
and function of the intracellular adaptor, MyD88 (also known
as myeloid differentiation primary response gene 88). In
addition, ablation of MyD88 expression within the immune
system not only limits recognition of common pathogens, but
also limits the effectiveness and extent of general pro-
inflammatory responses to multiple stimuli because MyD88
expression is also required for IL (interleukin)-1 and IL-18
Figure 1 MyD88 expression in the CNS, but not the peripheral immune system, leads to acute inflammatory responses similar to wild-
type
The experimental model has three steps. (i) Lethal whole-body irradiation of either wild-type (A and D) or MyD88-knockout (KO) mice
(B and C) kills bone marrow and peripheral immune cells, but not CNS microglia or CNS-resident cells. (ii) Supplementation of
irradiated mice with donor bone marrow from wild-type (B and D) or MyD88-knockout mice (A and C) leads to the repopulation of
the peripheral immune system by the donor bone marrow. This manipulation generates mice with selective expression of MyD88 in
either the CNS or the peripheral immune system. (iii) Injection and infection of CNS with live S. aureus. Inflammation is assessed 24 h
post-infection. Chimaeras (C) and (D) control for non-specific irradiation effects.
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receptor family signalling. Not surprisingly, MyD88-knockout
mice begin to lethally succumb to S. aureus infection 24 h
following intracerebral infection.
At first glance, the brain abscess model used by Kielian and
colleagues (Garg et al., 2009) would appear to confirm the
assumed division of labour between the immune system and
CNS (pro- compared with anti-inflammatory respectively).
Specifically, within hours of intracerebral injection of live S.
aureus, robustly activated peripheral immune cells (primarily
neutrophils) enter the CNS and come into close apposition
with the bacteria. By contrast, microglia preferentially
surround the margins of the brain abscess (rather than being
in direct contact with S. aureus), consistent with their
previously demonstrated functions in limiting both innate
and adaptive immune functions. In the commonly accepted
paradigm, rapid S. aureus-associated lethality in MyD88-
knockout mice is a predictable consequence of a han-
dicapped, immunodeficient peripheral immune system.
The study by Garg et al. (2009) used irradiation chimaeric
mice to selectively remove MyD88 expression from only the
peripheral immune system (Figure 1A) or from only the CNS
(Figure 1B). The naı¨ve prediction would be that mice in which
MyD88 is expressed in the peripheral immune system
(Figure 1B) would have immune responses most similar to
that observed in wild-type mice (Figure 1D). Similarly, the
immune responses in mice expressing MyD88 only in the CNS
(Figure 1A) should be most similar to complete MyD88-
knockout mice (Figure 1C) if CNS-resident cells play an
insignificant pro-inflammatory role in pathogen defence
against S. aureus.
Neither of these results were observed! Rather, expression
of MyD88 only in the CNS was sufficient for robust induction
of immune cell chemoattractants and recruitment of high
numbers of MyD88-knockout neutrophils into the CNS
following S. aureus infection. Surprisingly, the levels of
pro-inflammatory cytokines produced in the presence of
these immunodeficient MyD88-knockout neutrophils and
macrophages was equivalent to or higher than that observed
in S. aureus-infected wild-type mice.
Conversely, despite the disruption of the CNS vasculature
and blood–brain barrier following injection of S. aureus into
the CNS, immunocompetent MyD88-expressing neutrophils
failed to enter the infected MyD88-knockout CNS and no
cytokine responses were observed. Furthermore, mice with an
immunocompetent MyD88-expressing immune system had
higher bacterial burdens than complete MyD88-knockout
mice! These results suggest that MyD88 expression in the CNS
may play an unusual protective role offsetting the known
potential of bacteria to hijack MyD88-dependent pathways in
immune cells (Cirl et al., 2008).
One potential caveat to these studies should be considered.
Use of irradiation chimaeras recently has come into question
because irradiation facilitates inappropriate immune cell
entry and colonization of the CNS (reviewed in Ransohoff,
2007). In the present study (Garg et al., 2009), the lower
threshold for immune cell entry into the CNS provides a more
stringent test of whether there are CNS-intrinsic mechanisms
that cannot be replaced by the peripheral immune system.
CONSEQUENCES OF ACTIVE REGULATION
In summary, the majority of recent studies have focused on
defining the anti-inflammatory regulatory functions of CNS-
resident cells (Takahashi et al., 2007, reviewed in Carson et al.,
2006; Carson and Lo, 2007). Garg et al. (2009) provide a clear
demonstration that CNS-intrinsic mechanisms exist for
induction of pro-inflammatory immune responses that go
beyond merely expressing chemokines to recruit immune cells
to the site of CNS infection (Garg et al., 2009). Furthermore,
these mechanisms cannot be replaced or compensated for by
a fully functional peripheral immune system, at least with
regard to S. aureus infections of the CNS. These observations
are in stark contrast with those generated in models of
experimentally induced CNS autoimmunity initiated by
injection of strong immune stimulants and adjuvants outside
of the CNS (for example, subcutaneous injections of pertussis
toxin and complete Freund’s adjuvant) (reviewed in Carson et
al., 2006). In these types of experimentally induced
autoimmune model, CNS-resident cells play no necessary or
sufficient role in induction of pro-inflammatory autoimmune
responses. These latter types of data have served to focus
potential therapeutic manipulation of autoimmune inflam-
matory responses solely on the peripheral immune system.
This focus has yielded a mix of therapeutic approaches with
both promising and disappointing results in human clinical
trials. The current studies by Garg et al. (2009) suggest that
the dysregulation of either CNS-intrinsic anti- or pro-
inflammatory regulatory mechanisms could lead to inappro-
priate initiation of neuroinflammation and could contribute
toward the onset of CNS autoimmune or CNS neuro-
inflammatory disorders.
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